NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Glenmark Pharmaceuticals today said it has received the final approval from US health regulator for its generic version of desmopressin acetate tablets used in treatment of diabetes and bed-wetting. The approval by the US Food and Drug Administration (USFDA) is for strengths of 0.1 mg and 0.2 mg and the…

news

Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify. At the end of April, the FDA approved applications to make Abilify by several generic drugmakers, including Teva Pharmaceutical Industries Ltd, which immediately announced…

news

United States antitrust regulators have settled a long-running fight with Cephalon, now owned by Israel’s Teva Pharmaceuticals, over how it resolved a patent infringement lawsuit tied to wakefulness drug Provigil, the Federal Trade Commission said on Thursday. As part of the settlement, Teva, which bought Cephalon in 2012, agreed to…

news

Danaher Corporation announced that it has entered into a definitive merger agreement with Pall Corporation pursuant to which Danaher will acquire all of the outstanding shares of Pall for $127.20 per share in cash, or a total enterprise value of approximately $13.8 billion, including assumed debt and net of acquired…

news

Banks on new product pipeline, revenue falls to Rs 1,753 crore Orchid Chemicals & Pharmaceuticals (Orchid Pharma) has reported a net loss of Rs 191 crore during the year ended March 31, 2015 as compared to net loss of Rs 530 crore a year ago. Revenue in 2014-15 stood at…

news

Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, received a $10 million investment led by Shavit Capital in a Series A financing round that included participation by the company’s chairman and CEO Mr. Ehud Marom. The funding will be used to support the company’s clinical…

news

Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, received a $10 million investment led by Shavit Capital in a Series A financing round that included participation by the company’s chairman and CEO Mr. Ehud Marom. The funding will be used to support the company’s clinical…

news

The World Health Organization (WHO) has adopted a new global strategy to fight drug-resistant diseases like tuberculosis, malaria, urinary tract infection and even HIV at the 68th World Health Assembly, a forum that serves as the agency's highest decision-making body. It endorsed a global action plan to tackle anti-microbial resistance…

news

China's drug regulator has steeply raised the fees required to register drugs and medical devices in the world's second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process a rising number of applications. The fee for registering a new locally-made drug will soar to 624,000…

news

Drug developer GlobeImmune Inc said its experimental hepatitis B drug did not reduce infection in patients after 24 weeks of treatment in a mid-stage study, sending the company's shares down as much as 60 percent to a record low. GlobeImmune, which is developing the drug with Gilead Sciences Inc, is…